Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
In mid-September, the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) issued a joint statement confirming that biosimilar medicines approved in the European Union are interchangeable with their reference medicine or with an equivalent biosimilar. This joint statement brings more clarity for healthcare professionals and consequently will improve patients’ access to biological medicines across the EU.
Since 2006, EMA has been …
Competing interests None declared.
Provenance and peer review Commissioned; internally peer reviewed.